Specimen
Fresh venous blood
Volume
5 tubes (2.7ml/tube)
Container
3.2% Trisodium citrate tube
LTAT
8 weeks
Note
Specimen
Fresh venous blood or bone marrow
Volume
2 tubes
2.5-3.0 mL
Container
EDTA (K2)
LTAT
8-10 weeks
Note
Specimen
Whole blood
Serum
Volume
3.5ml
Container
Plain tube
LTAT
MDS: 8-10 weeks
MPN & PRV: 14 weeks
Note
Serum will be separated with minimum 1.5ml as soon as possible.
Store frozen serum at -40⁰C.
Transport frozen serum on dried ice.
Specimen
Fresh venous blood or bone marrow
Volume
2.5-5.0 mL
Container
EDTA (K2)
LTAT
3 weeks
Note
AML Mutation Panel by next generation sequencing (For patients at diagnosis or relapse only).
FLT3-ITD Mutation Analysis.
Specimen
Fresh venous blood or bone marrow
Volume
2.5-5 mL (2 tubes)
Container
EDTA (K2)
LTAT
4 weeks
Note
The sample must be accompanied with a copy of the qualitative BCR-ABL1 report at diagnosis and BCR-ABL1 quantitative reports.
Specimen
Fresh venous blood or bone marrow
Volume
2.5-5 mL (2 tubes)
Container
EDTA (K2)
LTAT
4 weeks
Note
For suspected cases of CML, MPN or MDS/MPN.
Specimen
Fresh venous blood and bone marrow
Volume
2.5-5.0 mL
Container
EDTA (K2)
LTAT
4 weeks
Note
For suspected cases of systemic mastocytosis.
Please use the latest form.
Recent FBC (within 3 months) and a copy of Hb analysis report must be attached. The attached FBC result must be labelled with 2 identifiers (name and IC/passport number).
All paediatrics (<12 y.o) sample to be referred to IMR, MUST be accompanied by both parents' FBC and Hb analysis results. Parents' samples are not required.
Consent form must be filled and signed by the patient or parents/guardian if the patient is less than 18 years old.
The request and consent form must be signed by medical officer.
Specimen
Fresh venous blood
Volume
2.5-3.0 mL
Container
EDTA (K2)
LTAT
150 days
Note
Please use the latest form.
All carrier screening must be accompanied by an index sample with separate request form.
A copy of the index and relative genetic test result (if available).
Family tree.
Consent form must be filled and signed by the patient or parents/guardian if the patient is less than 18 years old.
The request and consent form must be signed by medical officer.
Specimen
Fresh venous blood or bone marrow
Volume
2.5-5.0 mL
Container
EDTA (K2)
LTAT
3 weeks
Note
For acute leukaemia patients at diagnosis or relapse only.
Specimen
Bone marrow aspirate
Volume
1 tube 3.0-5.0mL
Container
Sodium Heparin tube
LTAT
120 days
Specimen
Fresh venous blood
Volume
1 tube 3.0-5.0mL
Container
Lithium Heparin tube
LTAT
120 days
Note
* By Appointment only, Call HTA : 03-26003000 Ext : 1136/1134
* Urgent Case without Appointment : Edward, Patau, DiGeorge, Down Syndrome, Forensic Case
*Reflex Testing : Constitutional molecular cytogenetics fluoresnce in situ Hybridizatiion (FISH) is done if indicated
It is MANDATORY to fill in the form with relevant clinical history and drug history (i.e. anticoagulant usage/ factor replacement therapy including date and time of last dose given).
Patient on anticoagulant or certain drugs should be discontinued as below:
Warfarin 2 weeks
Un-fractionated heparin (UFH) 24 hours
Low molecular weight heparin (e.g; clexane) 12-24 hours
Direct oral anticoagulant (e.g; dabigatran, apixaban) 72 hours
Emicizumab 6 months (Further reading)
For thrombophilia testing, please use this guideline
Testing should be delayed until at least 6 weeks after the acute event.
Arterial thrombotic event is not an indication for heritable thrombophilia study.
Testing for heritable thrombophilia study is not recommended in patient with CVC-related venous thrombosis.
Specimen
Fresh venous blood
Volume
5 tubes (2.7ml/tube)
Container
3.2% Trisodium citrate tube
LTAT
8 weeks
Note
To send immediately or within 30 minutes after blood collection.
Must have a complete and relevant clinical summary.
Specimen
Fresh venous blood
Volume
2 tubes
2.5-3.0 mL
Container
EDTA (K2)
LTAT
35 days
Note
To send immediately or within 30 minutes after blood collection.
Must have a complete and relevant clinical summary.
Avoid direct contact with ice.
Specimen kept for more than 48 hours is not suitable for analysis.
The sample must be fixed with TransFix®.
Specimen
Fresh venous blood
Volume
1 tubes
2.0 mL
Container
EDTA (K2)
LTAT
35 days
Note
To send immediately or within 30 minutes after blood collection.
Must have a complete and relevant clinical summary.
Avoid direct contact with ice.
Specimen kept for more than 48 hours is not suitable for analysis.
Specimen
Fresh venous blood
Volume
1 tubes
2.0 mL
Container
EDTA (K2)
LTAT
35 days
Note
To send immediately or within 30 minutes after blood collection.
Must have a complete and relevant clinical summary.
Avoid direct contact with ice.
Specimen kept for more than 48 hours is not suitable for analysis.
Please use the latest form.
Recent FBC (within 3 months) and a copy of Hb analysis report must be attached. The attached FBC result must be labelled with 2 identifiers (name and IC/passport number).
Consent form must be filled and signed by the patient or parents/guardian if the patient is less than 18 years old.
The request and consent form must be signed by medical officer.
Specimen
Fresh venous blood
Volume
2.5-3.0 mL
Container
EDTA (K2)
LTAT
120 days
Note
Indication:
FBP showed RBC morphology features of SAO in:
Neonatal anaemia/hyperbilirubinemia
Severe anaemia in adult and hemolysis picture
Both husband and wife with history of hydrop fetalis
Distal renal tubular acidosis
Suspected homozygous SAO
TDT and non-TDT thalassemia patient with co-inheritance SAO
Specimen
Fresh venous blood
Volume
3.0 mL (Adult)
1.0 mL (Paediatric)
Container
EDTA (K2)
LTAT
8 minggu
Note
PER-PAT form with consent.
PBF report with complete FBC parameters (within 3 months).
Sample to be sent within 1 week and kept in 2-8⁰C.